This page shows the latest VX-880 news and features for those working in and with pharma, biotech and healthcare.
Vertex says VX-880 has potential to restore pancreatic islet cell function, including insulin production, in type 1 diabetes patients. ... Vertex gained VX-880 from its previous acquisition of Semma Therapeutics for $950m in September 2019.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...